Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Vaccine|February 27, 2021
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataFlor M Munoz, Jakob P Cramer, Cornelia L Dekker, et al.
Nature Medicine|May 19, 2021
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19Brian J Ward, Philipe Gobeil, Annie Séguin, et al.
Plos One|August 19, 2024
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) studyJames Wright, Natasha Crowcroft, Elizabeth McLachlan, et al.
The Journal of Infectious Diseases|February 16, 2006
Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortalityJean H Humphrey, Peter J Iliff, Edmore T Marinda, et al.
The Lancet. Infectious Diseases|May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trialTimo Vesikari, Joanne M Langley, Nathan Segall, et al.
The New England Journal of Medicine|December 14, 2017
A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsLars Ostergaard, Timo Vesikari, Judith Absalon, et al.
Science Immunology|April 5, 2024
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humansLilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Cellular & Molecular Immunology|January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.
NPJ Vaccines|November 9, 2022
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without ComorbiditiesNathalie Charland, Philipe Gobeil, Stéphane Pillet, et al.
The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 VaccineKaren J Hager, Gonzalo Pérez Marc, Philipe Gobeil, et al.
Pageof 16